Skip to content

Emotional Processing in Multiple Sclerosis / Clinically Isolated Syndrome: A Neuropsychological fMRI-study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02695394
Enrollment
60
Registered
2016-03-01
Start date
2016-02-29
Completion date
2016-12-31
Last updated
2020-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinically Isolated Syndrome (CIS), Multiple Sclerosis (MS)

Brief summary

The aim of this prospective non-interventional neuropsychological one visit study involving functional MRI (fMRI) is to ascertain emotional processing in patients with Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS) compared to healthy control subjects. In different experiments, the modulation of cognitive and motor responses by visual emotional information and the ability to discriminate visual emotional stimuli will be tested using experimental behavioral paradigms. Furthermore, functional connectivity and - using fMRI - activations of brain regions known to be involved with emotional processing will be evaluated.

Interventions

None listed

Sponsors

NeuroCure Clinical Research Center, Charite, Berlin
CollaboratorOTHER
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 84 Years
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years and ≤ 85 years * Right handed * For patients: Diagnosis of CIS or diagnosis of MS since ≤5 years

Exclusion criteria

* Cognitive deficits as determined by a MMSE Score \< 25/30 * Depression as determined by a HADS-D Score \> 7 * Anxiety as determined by a HADS-A Score \> 7 * Physical disabilities interfering with the study procedures or impacting outcome measures * Clinically significant diseases within 7 days prior to the study evaluations * Contraindications against cranial MRI without contrast

Design outcomes

Primary

MeasureTime frameDescription
Emotional modulation of motor response time1 dayΔ (\[Response time following neutral stimuli\] - \[Response time following emotional stimuli\])
Emotional memory performance1 day%-correct recognized emotional and neutral stimuli
Emotional experience1 daySubjective valence and arousal ratings of emotional and neutral stimuli

Secondary

MeasureTime frame
Short Form Health Survey (SF-36)1 day
Satisfaction With Life Scale (SWLS)1 day
Paced Auditory Serial Addition Test (PASAT)1 day
BOLD-fMRI brain responses during emotional processing1 day
Symbol Digit Modalities Test (SDMT)1 day
Beck depression inventory BDI-21 day
Positive and Negative Affect Schedule (PANAS)1 day
Serial Reaction Time (SRT) Task1 day
Expanded Disability Status Scale (EDSS)1 day
Multiple Sclerosis Functional Composite (MSFC)1 day

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026